EMCDDA Home
  • EN
Search

Figure TDI-1. Trend in estimated number of new clients entering treatment by primary drug used, from 2006–11

Part (ii) Numbers of clients by primary drug

 
 
Primary drug200620072008200920102011
Related links:
Heroin552355949352255487404357141682
Cocaine356163692837880352473230230793
Cannabis457404849747571564805955660626
Other stimulants1004910859909479041047011613
Other drugs123191027311712128041270112735
Not known / missing111794138792592551542215747
Statistical bulletin 2013
See also ‘General notes for interpreting data’ on the Explanatory notes and help page

Notes:

Missing data were interpolated by assigning for the respective country the value for most recent year available. Altogether, 3.5% of the data points and 8.0% of the number of clients were interpolated.

Countries included: Bulgaria, Czech Republic, Denmark, Germany, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Lithuania, Hungary, Netherlands, Austria, Portugal, Romania, Slovakia, Slovenia, Finland, Sweden, United Kingdom, Croatia and Turkey.

Sources:

Reitox national reports 2012

Primary drug 2006 2007 2008 2009 2010 2011
Heroin 55235 59493 52255 48740 43571 41682
Cocaine 35616 36928 37880 35247 32302 30793
Cannabis 45740 48497 47571 56480 59556 60626
Other stimulants 10049 10859 9094 7904 10470 11613
Other drugs 12319 10273 11712 12804 12701 12735
Not known / missing 11179 4138 7925 9255 15422 15747

tdifig1b

 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 08 May 2013